Literature DB >> 9155033

The binding of a Fos/Jun heterodimer can completely disrupt the structure of a nucleosome.

K W Ng1, P Ridgway, D R Cohen, D J Tremethick.   

Abstract

An important first step in the chromatin remodelling process is the initial binding of a transcriptional activator to a nucleosomal template. We have investigated the ability of Fos/Jun (a transcriptional activator involved in the signal transduction pathway) to interact with its cognate binding site located in the promoter region of the mouse fos-related antigen-2 (fra-2) promoter, when this site was reconstituted into a nucleosome. Two different nucleosome assembly systems were employed to assemble principally non-acetylated or acetylated nucleosomes. The ability of Fos/Jun to interact with an acetylated or an unacetylated nucleosome differed markedly. Fos/Jun bound to an unacetylated nucleosome with only a 4- to 5-fold reduction in DNA binding affinity compared with naked DNA. Strikingly, the binding of Fos/Jun to a single high-affinity site incorporated into an acetylated nucleosome resulted in the complete disruption of nucleosomal structure without histone displacement. Moreover, this disruption was sufficient to facilitate the subsequent binding of a second transcription factor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155033      PMCID: PMC1169810          DOI: 10.1093/emboj/16.8.2072

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  31 in total

1.  Fos and jun cooperate in transcriptional regulation via heterologous activation domains.

Authors:  C Abate; D Luk; E Gagne; R G Roeder; T Curran
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

2.  Nucleosome linking number change controlled by acetylation of histones H3 and H4.

Authors:  V G Norton; K W Marvin; P Yau; E M Bradbury
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

3.  The effects of salt concentration and H-1 depletion on the digestion of calf thymus chromatin by micrococcal nuclease.

Authors:  W O Weischet; J R Allen; G Riedel; K E Van Holde
Journal:  Nucleic Acids Res       Date:  1979       Impact factor: 16.971

4.  Accessibility of a glucocorticoid response element in a nucleosome depends on its rotational positioning.

Authors:  Q Li; O Wrange
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

5.  Purification and properties of an ATP-dependent nucleosome remodeling factor.

Authors:  T Tsukiyama; C Wu
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

6.  Structure of chromatin containing extensively acetylated H3 and H4.

Authors:  R T Simpson
Journal:  Cell       Date:  1978-04       Impact factor: 41.582

7.  The histone H3/H4.N1 complex supplemented with histone H2A-H2B dimers and DNA topoisomerase I forms nucleosomes on circular DNA under physiological conditions.

Authors:  K Zucker; A Worcel
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

8.  Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.

Authors:  C Van Lint; S Emiliani; M Ott; E Verdin
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

9.  Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron.

Authors:  G Bergers; P Graninger; S Braselmann; C Wrighton; M Busslinger
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

Review 10.  The SWI-SNF complex: a chromatin remodeling machine?

Authors:  C L Peterson; J W Tamkun
Journal:  Trends Biochem Sci       Date:  1995-04       Impact factor: 13.807

View more
  22 in total

1.  Structural and functional cross-talk between a distant enhancer and the epsilon-globin gene promoter shows interdependence of the two elements in chromatin.

Authors:  J C McDowell; A Dean
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Epstein-Barr nuclear antigen 1 binds and destabilizes nucleosomes at the viral origin of latent DNA replication.

Authors:  T M Avolio-Hunter; P N Lewis; L Frappier
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

3.  DNA repair of a single UV photoproduct in a designed nucleosome.

Authors:  J V Kosmoski; E J Ackerman; M J Smerdon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

4.  Targeted histone acetylation at the yeast CUP1 promoter requires the transcriptional activator, the TATA boxes, and the putative histone acetylase encoded by SPT10.

Authors:  Chang-Hui Shen; Benoit P Leblanc; Carolyn Neal; Ramin Akhavan; David J Clark
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

5.  Two-step binding of transcription factors causes sequential chromatin structural changes at the activated IL-2 promoter.

Authors:  Satoru Ishihara; Ronald H Schwartz
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

Review 6.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

Review 7.  Role of transcription factors in inflammatory lung diseases.

Authors:  I Rahman; W MacNee
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

8.  Histone acetylation facilitates RNA polymerase II transcription of the Drosophila hsp26 gene in chromatin.

Authors:  K P Nightingale; R E Wellinger; J M Sogo; P B Becker
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

9.  Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation.

Authors:  Irfan Rahman; Peter S Gilmour; Luis Albert Jimenez; William MacNee
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

10.  The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression.

Authors:  W Stünkel; H U Bernard
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.